The Liver Meeting 2019-Ethical & Practical Considerations in Transplantation from HCV+ Donors

Ethical & Practical Considerations in Transplantation from HCV+ Donors

Video Transcription

Video Summary

The speaker addresses the potential of using organs from HCV viremic donors to help reduce the organ transplant waiting list, emphasizing the positive impact these organs can have on decreasing wait times and expanding the donor pool. While the short-term outcomes seem promising with comparable results to organs from negative donors, there are concerns about potential long-term effects and complications, such as rejection and other infections. The presentation also raises ethical questions regarding the equitable distribution of these organs, consent procedures, and managing drug interactions post-transplant. Practical challenges, such as insurance coverage for treatment and monitoring for complications, are discussed, highlighting the need for careful planning, shared decision-making, and ongoing research to ensure the safe and effective use of HCV viremic organs in transplantation.

Asset Caption

Presenter: Emily Blumberg

Keywords

organs from HCV viremic donors

organ transplant waiting list

long-term effects

ethical questions

insurance coverage

transplantation